Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Quantin

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancerMohammad Chakra, Jean Louis Pujol, Pierre-Jean Lamy, et al.
Journal of Dual Diagnosis|December 20, 2015
Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms: A Randomized Controlled Pilot TrialPaquito Bernard, Gregory Ninot, Fabienne Cyprien, et al.
Respiratory Medicine and Research|June 12, 2023
Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapyClarisse Audigier Valette, Thomas Filleron, Didier Debieuvre, et al.
Journal of Geriatric Oncology|January 19, 2023
Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohortMichael Bringuier, Matthieu Carton, Didier Debieuvre, et al.
Clinical Chemistry and Laboratory Medicine|April 8, 2018
Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancerJérôme Solassol, Xavier Quantin, Marion Larrieux, et al.
Cancer Medicine|June 7, 2026
Retrospective Analysis of HER2 Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC With HER2 Mutations in FranceDidier Debieuvre, Pauline Macouillard, Xavier Quantin, et al.
Cancers|March 13, 2024
Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative StudyQuentin Dominique Thomas, Mohamed Chaabouni, Anas Al Herk, et al.
Addictive Behaviors|December 22, 2023
Neuropsychological assessment fails to predict relapse among cigarette smokers: A prospective study of neurocognitive abilitiesValentin Flaudias, Corentin Gonthier, Marie Christine Picot, et al.
Respiratory Medicine and Research|December 30, 2025
Real-world outcomes of patients treated with ≥17 cycles of pembrolizumab monotherapy as first-line therapy and for previously treated advanced NSCLC: multicenter observational study in FranceMaurice Pérol, Clarisse Audigier-Valette, Hervé Léna, et al.
Plos One|March 9, 2016
Executive Functions in Tobacco Dependence: Importance of Inhibitory CapacitiesValentin Flaudias, Marie Christine Picot, Jorge Lopez-Castroman, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancerMohammad Chakra, Jean Louis Pujol, Pierre-Jean Lamy, et al.
Journal of Dual Diagnosis|December 20, 2015
Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms: A Randomized Controlled Pilot TrialPaquito Bernard, Gregory Ninot, Fabienne Cyprien, et al.
Respiratory Medicine and Research|June 12, 2023
Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapyClarisse Audigier Valette, Thomas Filleron, Didier Debieuvre, et al.
Journal of Geriatric Oncology|January 19, 2023
Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohortMichael Bringuier, Matthieu Carton, Didier Debieuvre, et al.
Clinical Chemistry and Laboratory Medicine|April 8, 2018
Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancerJérôme Solassol, Xavier Quantin, Marion Larrieux, et al.
Cancer Medicine|June 7, 2026
Retrospective Analysis of HER2 Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC With HER2 Mutations in FranceDidier Debieuvre, Pauline Macouillard, Xavier Quantin, et al.
Cancers|March 13, 2024
Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative StudyQuentin Dominique Thomas, Mohamed Chaabouni, Anas Al Herk, et al.
Addictive Behaviors|December 22, 2023
Neuropsychological assessment fails to predict relapse among cigarette smokers: A prospective study of neurocognitive abilitiesValentin Flaudias, Corentin Gonthier, Marie Christine Picot, et al.
Respiratory Medicine and Research|December 30, 2025
Real-world outcomes of patients treated with ≥17 cycles of pembrolizumab monotherapy as first-line therapy and for previously treated advanced NSCLC: multicenter observational study in FranceMaurice Pérol, Clarisse Audigier-Valette, Hervé Léna, et al.
Plos One|March 9, 2016
Executive Functions in Tobacco Dependence: Importance of Inhibitory CapacitiesValentin Flaudias, Marie Christine Picot, Jorge Lopez-Castroman, et al.
Pageof 9